1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Global Sleep Apnea Market Outlook 2020

Global Sleep Apnea Market Outlook 2020

  • January 2016
  • -
  • RNCOS
  • -
  • 95 pages

Summary

Table of Contents

Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway. It is also the most common type of sleep apnea seen in people. An untreated sleep apnea can increase the risk of high blood pressure, heart attack, stroke, obesity, and diabetes. It also increases the risk of, or worsen, heart failure and the chances of having work-related or driving accidents.

According to a new analysis from RNCOS in “Global Sleep Apnea Market Outlook 2020” report, the global sleep apnea therapeutic devices market is anticipated to grow at a CAGR of 7.5% during the forecast period (2015-2020). The market growth is expected mainly due to the growing incidences of sleep-related breathing disorders, increasing awareness about sleep apnea coupled with the rising incidences of obesity.

According to the analysis by RNCOS, conventional Positive Airway Pressure (PAP) devices continue to dominate the market in terms of the therapeutic devices used for the treatment of sleep apnea; however it is the oral appliances segment that is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the fact that oral appliancesare small and discreet and easily potable as compared to the conventional devices.

Also, in terms of application of the devices, obstructive sleep apnea is most commonly observed amongst all the three types of sleep apnea; however, central sleep apnea has an increasing incidence in patients with heart diseases. In terms of geography, North America is the largest market forsleep apnea therapeutic devices market, but it is the Asia Pacific market, which is expected to witness the highest growth, largely due to improving medical facilities, growing awareness, and increasing focus of various players in this region.The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020.

The report also provides details about innovative therapies that are now increasingly available in the market, as alternatives to the conventional PAP–based therapy. The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Philips Respironics, ResMed, Fisher, and Paykel, among others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player’s business model, the player’s current and historical financials have been analysed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends, which will likely generate key interest in investors thinking about joining the industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • March 2017
  • by Transparency Market Research

Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; ...

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.